Clinical Trials on Meningioma, Malignant

Total 4539 results

Northwestern University
National Cancer Institute (NCI); NovoCure Ltd.

Recruiting

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

Atypical Meningioma | Grade III Meningioma | Recurrent Meningioma | Anaplastic (Malignant) Meningioma | Grade II Meningioma | Supratentorial Meningioma

United States
Assistance Publique Hopitaux De Marseille

Completed

Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas (CEVOREM)

Recurrent Meningiomas | Resistant Meningiomas

France
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group

Terminated

S9624 Ifosfamide in Treating Patients With Meningeal Tumors

Chondrosarcoma | Adult Rhabdomyosarcoma | Adult Fibrosarcoma | Adult Leiomyosarcoma | Adult Malignant Meningioma | Adult Brain Malignant Hemangiopericytoma

United States, Australia, Peru, Puerto Rico
Istituto Oncologico Veneto IRCCS
Bayer

Not yet recruiting

Regorafenib for Recurrent Grade 2 and 3 Meningioma (MIRAGE Trial) (MIRAGE)

Meningioma, Malignant

Italy
Beijing Tiantan Hospital

Recruiting

Exploratory Study of PD-1 Neoadjuvant Treatment of Recurrent Meningioma

Meningioma, Malignant

China
University Hospital, Montpellier
Centre Hospitalier Universitaire de Besancon

Recruiting

Oncological Care for Patients With Meningioma (ATYPICMENING)

Atypical Meningioma | Anaplastic Meningioma | Clear-cell Meningioma | Chordoid Meningioma | Rhabdoid Meningioma | Papillary Meningioma

France
Dana-Farber Cancer Institute
Bristol-Myers Squibb

Recruiting

An Open-Label Phase II Study of Nivolumab in Adult Participants With Progessive/ Recurrent Meningioma

Meningiomas

United States
Beijing Sanbo Brain Hospital

Recruiting

Apatinib in the Treatment of Recurrent Atypical/Malignant Meningioma in Adults

Recurrent Atypical/Malignant Meningioma

China
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

Grade 1 Meningioma | Grade 2 Meningioma | Grade 3 Meningioma | Recurrent Meningioma | Unresectable Meningioma

United States
National Cancer Institute (NCI)

Recruiting

Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers

Ependymoma | Medulloblastoma | Pineal Region Tumors | Choroid Plexus Tumors | Atypical/Malignant Meningioma

United States
RenJi Hospital

Unknown

Effects of Scalp Nerve Blocks on Systemic Inflammation

Meningiomas

China
Kasr El Aini Hospital

Unknown

Neurocognitive Outcome Assesment in Patients With Peri-optic Meningiomas After Excision With Or Without Pealing Of The Outer Layer Of The Cavernous Sinus: A Randomized Controlled Single Blinded Trial.

Neurocognitive Outcome Assesment in Patients With Perioptic Meningiomas
Kasr El Aini Hospital

Unknown

Cavernous Sinus Dissection and Bleeding in Meningiomas (OCS)

Meningiomas of the Middle Cranial Fossa

Egypt
University of Chicago
Stand Up To Cancer

Recruiting

Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials

Cancer | Malignant Neoplasm | Malignancy

United States
Nancy Ann Oberheim Bush, MD
Merck Sharp & Dohme LLC

Recruiting

Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma

Recurrent Meningioma | Grade I Meningioma, Adult | Grade II Meningioma, Adult | Grade III Meningioma, Adult

United States
National Cancer Institute (NCI)

Recruiting

Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma

Grade 2 Meningioma | Grade 3 Meningioma | Recurrent Meningioma

United States
National Cancer Institute (NCI)

Completed

Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma

Adult Anaplastic Astrocytoma | Adult Anaplastic Oligodendroglioma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain Tumor | Adult Grade I Meningioma | Adult Grade II Meningioma | Adult Grade III Meningioma

United States
University of Nebraska
Chimerix

Not yet recruiting

A Study of ONC201 for Refractory Meningioma

Meningioma | Refractory Meningioma | Relapsed Meningioma

United States
NRG Oncology
National Cancer Institute (NCI)

Recruiting

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

Intracranial Meningioma | Grade II Meningioma

Canada, United States, Japan, Saudi Arabia, India
Wake Forest University Health Sciences

Completed

Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors

Glioblastoma Multiforme | Anaplastic Astrocytoma | Brain Neoplasms, Benign | Brain Neoplasms, Malignant | Malignant Meningioma

United States
Ohio State University

Recruiting

Cognitive Status After Removal of Skull Base Meningioma

Cognitive Impairment | Cognitive Decline | Meningioma | Skull Base Meningioma | Frontal Meningioma | Temporal Meningioma | Post-Surgical Cognition

United States
Royal Marsden NHS Foundation Trust
University College London Hospitals; University of Southampton; St George's University... and other collaborators

Completed

Information Needs Around Parenteral nUTrition in Cancer (INPUT)

Neoplasms | Cancer | Tumor | Malignant Neoplasm | End Stage Cancer | Malignancy | Terminal Cancer

United Kingdom
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Predictive Factors for Survival in Aggressive Meningiomas (23Men)

Meningioma | Anaplastic Meningioma | Meningioma Atypical

Italy
National Cancer Institute (NCI)

Completed

Imatinib Mesylate in Treating Patients With Recurrent Meningioma

Recurrent Adult Brain Tumor | Adult Grade I Meningioma | Adult Grade II Meningioma | Adult Meningeal Hemangiopericytoma | Adult Meningioma | Adult Grade III Meningioma

United States
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Cellular Immunotherapy Study for Brain Cancer (alloCTL)

Glioblastoma Multiforme | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma | Gliomas | Anaplastic Mixed Glioma | Malignant Meningioma

United States
Tata Memorial Hospital
Terry Fox Foundation

Unknown

SCRT Versus Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumors (SCRT)

Craniopharyngioma | Meningiomas | Ependymomas | Low Grade Gliomas

India
Rabin Medical Center

Unknown

A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma

Hemangiopericytoma | Atypical Meningioma | Anaplastic Meningioma

Israel
Emory University
National Cancer Institute (NCI)

Not yet recruiting

Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial

Meningioma | Low Grade Glioma | Malignant Brain Neoplasm | Malignant Brain Glioma

United States
Central Hospital, Nancy, France

Unknown

Study of the Inflammatory Microenvironment in Atypical Meningiomas

Atypical Meningioma

France
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); GlaxoSmithKline; Genentech, Inc.; Brain Science...

Recruiting

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Intracranial Meningioma | Recurrent Meningioma | NF2 Gene Mutation

United States
Central Hospital, Nancy, France
Institut National de la Santé Et de la Recherche Médicale, France

Recruiting

Identification by Transcriptomic Approach of New Prognostic and Predictive Markers in a Cohort of Atypical Meningiomas (TransMenAtyp)

Meningioma Atypical

France
SCRI Development Innovations, LLC
Novartis; Genentech, Inc.

Terminated

Trial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial Meningioma

Intracranial Meningioma

United States
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...

Active, not recruiting

Multisession Radiosurgery in Large Meningiomas (MuRaLM)

Intracranial Meningioma

Italy
Colombian Foundation for Epilepsy and Neurological...

Unknown

Efficacy of Tranexamic Acid in Brain Tumor Resections (COLFIRE)

Neoplasms | Brain Tumors | Gliomas | Astrocytomas | Meningiomas

Colombia
Central Hospital, Nancy, France

Completed

Semi-automated Segmentation Methods of SSTR PET for Dosimetry Prediction (177Lumen)

Refractory Meningioma

France
University Hospital Heidelberg

Withdrawn

Comparison of Proton and Carbon Ion Radiotherapy With Advanced Photon Radiotherapy in Skull Base Meningiomas: The PINOCCHIO Trial. (PINOCCHIO)

Skull Base Meningioma

Germany
Fondation Ophtalmologique Adolphe de Rothschild

Recruiting

Predictive Factors of Visual Recovery After Paraoptic Tumors Removal (PRONOPTIC)

Tuberculum Sellae Meningioma

France
Xiangya Hospital of Central South University

Completed

Clinical Outcomes and Decision-making Choice of Skull Base Approaches for Petroclival Meningiomas

Skull Base Meningioma

China
Ethicon, Inc.
Guangzhou Bioseal Biotechnology Co., Ltd.

Completed

Phase IV Bioseal Study in Brain Tumor Surgery

Hemostasis | Meningioma Surgery

China
Assiut University

Unknown

Sphenoorbital Meningioma Management.

Brain Meningioma
National Cancer Institute (NCI)

Terminated

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma

Recurrent Melanoma | Stage IV Melanoma | Acral Lentiginous Malignant Melanoma | Lentigo Maligna Malignant Melanoma | Nodular Malignant Melanoma | Solar Radiation-related Skin Melanoma | Superficial Spreading Malignant Melanoma

United States
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...

Recruiting

Multisession Radiosurgery in Residual/Recurrent Grade II Meningiomas. (ATM)

Meningioma Atypical

Italy
Massachusetts General Hospital

Completed

Proton/Photon Rt - Benign Meningiomas(P92-13)

Benign Meningioma

United States
Washington University School of Medicine
Pfizer

Terminated

Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory Meningioma

Meningioma | Meningioma, Adult

United States
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group

Completed

S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma

Adult Meningioma

United States
Chang Gung Memorial Hospital

Not yet recruiting

Cognition-preserving Brain Irradiation for Treating Patients With Intracranial Meningioma in the Era of Modern Radiotherapeutic Techniques Including Proton Beam Therapy - a Prospective Study Focusing on Radiological Outcomes and Neurocognitive Endpoints

Intracranial Meningioma

Taiwan
Massachusetts General Hospital
Merck Sharp & Dohme LLC

Active, not recruiting

Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma

High Grade Meningioma

United States
Duke University

Terminated

Procedural Outcomes in Endobronchial Ultrasound - Transbronchial Needle Aspiration (EBUS-TBNA) With and Without Rapid On-Site Evaluation (ROSE) (ROSE)

ENDOBRONCHIAL ULTRASOUND - TRANSBRONCHIAL NEEDLE ASPIRATION | Benign and Malignant Mediastinal and Hilar Lymph Nodes Known or Suspected Malignancy

United States
Emory University
National Cancer Institute (NCI)

Recruiting

Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study (HiPPI)

Schwannoma | Grade III Meningioma | Intracranial Neoplasm | Nerve Sheath Neoplasm | Grade II Meningioma | Grade I Meningioma | Pituitary Gland Adenoma

United States
Assaf-Harofeh Medical Center

Unknown

Hyperbaric Oxygen Therapy Can Improve Neurological State Post Meningioma Removal Surgery

Intracranial Meningioma | Neurologic Deficits

Israel

Clinical Trials on Meningioma, Malignant

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations